Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-27 Purchase |
2023-11-29 4:09 pm |
Xeris Biopharma Holdings Inc. | XERS | SHERMAN JEFFREY W Director |
5,400 | $1.87 | $10,098 | 113,278 (Indirect Direct) |
View |
| 2023-11-20 Purchase |
2023-11-21 4:20 pm |
Xeris Biopharma Holdings Inc. | XERS | HALKUFF DAWN Director |
5,410 | $1.84 | $9,954 | 62,910 (Indirect Direct) |
View |
| 2023-11-20 Purchase |
2023-11-21 4:16 pm |
Xeris Biopharma Holdings Inc. | XERS | Pieper Steven See Remarks |
28,000 | $1.95 | $54,600 | 1,176,912 (Direct) |
View |
| 2023-11-16 Purchase |
2023-11-17 6:35 pm |
Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director |
6,500 | $1.51 | $9,815 | 69,659 (Indirect Direct) |
View |
| 2023-11-17 Purchase |
2023-11-17 5:58 pm |
Xeris Biopharma Holdings Inc. | XERS | Shannon John Patrick Jr See Remarks |
30,769 | $1.638 | $50,400 | 1,408,575 (Direct) |
View |
| 2023-11-14 Purchase |
2023-11-15 4:13 pm |
Xeris Biopharma Holdings Inc. | XERS | PERSKY MARLA Director |
6,370 | $1.5789 | $10,058 | 63,870 (Indirect Direct) |
View |
| 2023-08-09 Purchase |
2023-08-09 6:57 pm |
Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks |
10,000 | $2.3794 | $23,794 | 2,321,494 (Indirect Direct) |
View |
| 2022-12-13 Purchase |
2022-12-14 4:11 pm |
Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks |
20,000 | $1.45 | $29,000 | 1,561,494 (Indirect Direct) |
View |
| 2022-05-12 Purchase |
2022-05-13 4:19 pm |
Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks |
100,000 | $1.4038 | $140,380 | 1,541,494 (Indirect Direct) |
View |
| 2022-02-22 Sale |
2022-02-24 4:28 pm |
Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
11,228 | $2.4188 | $27,158 | 569,780 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-31 Option Award |
2024-01-31 5:04 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
175,000 | $0 | 446,860 (Direct) |
View |
| 2024-01-31 Option Award |
2024-01-31 5:04 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
750,000 | $0 | 1,554,968 (Direct) |
View |
| 2024-01-31 Option Award |
2024-01-31 5:04 pm |
N/A 2026-03-03 |
Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks |
2,000,000 | $0 | 4,321,494 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-07 5:02 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director |
42,500 | $0 | 57,500 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-07 5:00 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Kong Garheng Director |
42,500 | $0 | 107,670 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-07 4:59 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director |
42,500 | $0 | 535,812 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-07 4:58 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | HALKUFF DAWN Director |
42,500 | $0 | 57,500 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-07 4:56 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | PERSKY MARLA Director |
42,500 | $0 | 57,500 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-07 4:55 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director |
42,500 | $0 | 63,159 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-07 4:52 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | SHERMAN JEFFREY W Director |
42,500 | $0 | 107,878 (Direct) |
View |
| 2023-03-27 Option Award |
2023-03-29 4:53 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Fairley Ricki Louise Director |
85,000 | $0 | 85,000 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-01 4:13 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Shannon John Patrick Jr See Remarks |
750,000 | $0 | 1,377,806 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-01 4:13 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks |
750,000 | $0 | 2,311,494 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-01 4:13 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Pieper Steven See Remarks |
750,000 | $0 | 1,148,912 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-01 4:12 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
150,000 | $0 | 719,780 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-01 4:12 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
350,000 | $0 | 797,758 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-01 4:12 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
100,000 | $0 | 269,783 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 7:05 pm |
2022-06-08 2032-06-08 |
Xeris Biopharma Holdings Inc. | XERS | Kong Garheng Director |
40,000 | $0 | 90,170 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 5:15 pm |
2022-06-08 2032-06-08 |
Xeris Biopharma Holdings Inc. | XERS | SHERMAN JEFFREY W Director |
40,000 | $0 | 90,378 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 5:15 pm |
2022-06-08 2032-06-08 |
Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director |
25,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 5:15 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | BORMANN-KENNEDY BARBARA-JEAN ANNE Director |
15,000 | $2.1 | 40,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 5:14 pm |
2022-06-08 2032-06-08 |
Xeris Biopharma Holdings Inc. | XERS | PERSKY MARLA Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 5:14 pm |
2022-06-08 2032-06-08 |
Xeris Biopharma Holdings Inc. | XERS | HALKUFF DAWN Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 5:13 pm |
2022-06-08 2032-06-08 |
Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director |
40,000 | $0 | 45,659 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 5:13 pm |
2022-06-08 2032-06-08 |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director |
40,000 | $0 | 518,312 (Direct) |
View |
| 2022-02-22 Exercise |
2022-02-24 4:28 pm |
2022-02-22 2022-02-23 |
Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
11,228 | $0 | 569,780 (Direct) |
View |
| 2022-02-22 Exercise |
2022-02-24 4:28 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | PRESTRELSKI STEVEN Chief Scientific Officer |
11,228 | $0.69 | 569,780 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:03 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Pieper Steven See Remarks |
200,000 | $0 | 388,834 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 6:17 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | JOHNSON KENNETH ERLAND See Remarks |
75,000 | $0 | 165,865 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 6:16 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Hecht Beth See Remarks |
225,000 | $0 | 436,821 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 6:16 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Shannon John Patrick Jr See Remarks |
250,000 | $0 | 618,910 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 6:16 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Edick Paul R See Remarks |
600,000 | $0 | 1,441,494 (Direct) |
View |